What our users are saying

Rowan is proud to support leading researchers and organizations advancing discovery in the life and materials sciences. Here's what a few of our users have said about using the Rowan platform:

Arda Göreci · Founder & CTO, Ligo Biosciences
Enzyme design
Rowan's tools for modeling and predicting chemical reactivity have significantly accelerated our computational pipeline and have been a big asset to our team.

Trusted by

6,000+

scientists

Over

1.4 million

calculations run

Gilles Ouvry · VP of Chemistry, NRG Therapeutics
Neurotherapeutics
The game-changer for me this past year has been Rowan Scientific's platform which allows easy and quick access to hydrogen-bond basicity predictions. Read more.

Our partners & friends

ReSync Bio (acquired by Benchling)
Accelerating drug discovery with AI
Rowan partnered with ReSync to add powerful simulation tooling to the ReSync platform, which gave scientists no-code access to advanced AI tools. ReSync was acquired by Benchling in August 2025. Read more.
Banner background image